Flerobuterol
- Level
- Commodity
- Parent
- 51291700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51291706This classification denotes a beta-adrenergic agonist and antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F05RR5M463. European Medicines Agency schedules Flerobuterol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07638MIG. Flerobuterol generally arises in the molecular formula C12H18FNO. The term FLEROBUTEROL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) FLEROBUTEROL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flerobuterol under HS 29221980 and SITC 51461. As of Q4 2014, FLEROBUTEROL remains the US FDA Preferred Term for this commodity. Flerobuterol bears US NLM identifiers UMLS ID C0117861 and NCI Concept Code C65691. SMILES: CC(C)(C)NCC(C1=CC=CC=C1F)O.
Same parent
Under 51291700 · 12Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.